International Forum of Allergy & Rhinology最新文献

{"title":"Chronic Rhinosinusitis and Recalcitrant Disease in Liver Transplantation: What Have We Learned from This?","authors":"Hanwen Yang, Simeng Lei, Zhili JI","doi":"10.1002/alr.23592","DOIUrl":"10.1002/alr.23592","url":null,"abstract":"","PeriodicalId":13716,"journal":{"name":"International Forum of Allergy & Rhinology","volume":"15 5","pages":"570-571"},"PeriodicalIF":7.2,"publicationDate":"2025-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143810972","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Factors Influencing Discrepancy Between Skin Prick Test and Serum-Specific Immunoglobulin E Test Results.","authors":"Jayoung Oh, Jae-Chul Ahn, Yunhee Choi, Heung-Woo Park, Dong-Young Kim, Chae-Seo Rhee, Doo Hee Han","doi":"10.1002/alr.23588","DOIUrl":"https://doi.org/10.1002/alr.23588","url":null,"abstract":"","PeriodicalId":13716,"journal":{"name":"International Forum of Allergy & Rhinology","volume":" ","pages":"e3588"},"PeriodicalIF":7.2,"publicationDate":"2025-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143780055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Inflammatory Mediator Profiles in the Unchallenged Sinonasal Mucus of Allergic Rhinitis Patients Set to Begin Allergen Immunotherapy.","authors":"Cameron P Worden, Adam M Speen, Meghan E Rebuli, Ilona Jaspers, Brian D Thorp, Cristine N Klatt-Cromwell, Brent A Senior, Adam J Kimple, Charles S Ebert","doi":"10.1002/alr.23583","DOIUrl":"https://doi.org/10.1002/alr.23583","url":null,"abstract":"","PeriodicalId":13716,"journal":{"name":"International Forum of Allergy & Rhinology","volume":" ","pages":"e23583"},"PeriodicalIF":7.2,"publicationDate":"2025-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143780056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Radiofrequency Ablation of Inferior Turbinates With Laser Posterior Nasal Nerve Neurolysis for the Treatment of Chronic Rhinitis","authors":"Yi-Li Hwang, Jyun-Yi Liao, Ying-Shuo Hsu, Ming-Shao Tsai, Ting-Yu Shih, Han-Lo Teng, Bor-Hwang Kang, Chien-Yu Huang","doi":"10.1002/alr.23580","DOIUrl":"10.1002/alr.23580","url":null,"abstract":"<p>Posterior nasal nerve neurolysis (PNNN) is a potential approach for treating chronic rhinitis among patients unresponsive to pharmacological therapy [<span>1</span>]. However, the treatment response was not immediate. Studies by Lee and Takashima found a response rate of 67.5%–76.2% at 3 months and varied up to 80.6%–85.5% at 12 months [<span>2, 3</span>]. These radiofrequency (RF) PNNN devices have also been patented and can only be legally used in the US; hence, other countries have been left with no effective modality to support the use of PNNN. Other modalities to perform PNNN include Krespi et al., who proposed using a diode laser to perform PNNN [<span>4</span>], and Samy et al., who used RF ablation of the posterior end of the inferior turbinate to treat the peripheral branches of the posterior nasal nerve [<span>5</span>] showed significant improvement in chronic rhinitis symptoms.</p><p>With this background, we hypothesized that combining radiofrequency ablation of inferior turbinates and intraturbinate segments of the posterior nasal nerve (RAPN) with laser PNNN (collectively abbreviated as RPN3) may improve short-term response rates and enhance symptom control.</p><p>The inclusion criteria were: age 18–65 years, chronic rhinitis refractory to medical treatment for >6 months with at least 4 weeks of medical treatments, rTNSS ≥ 5, rhinorrhea ≥2, and congestion ≥2. The exclusion criteria were rhinosinusitis, difficult posterior nasal passage, concurrent other or previous nasal surgery in the nasal and oral area, and rhinitis medicamentosa.</p><p>RPN3 surgery was performed as day surgery under local anesthesia in the operating room. Septoplasty was not performed in all cases. First, RAPN was performed using an Olympus Celon Elite ESG-400 (Olympus Europa, Hamburg, Germany) at 15 W with a needle RF probe. RF was applied to the turbinate and ablated the head, middle and posterior aspect of the inferior turbinate, including the mulberry, and the superior, medial and inferior aspect of the posterior end of the turbinates, aiming to reduce the intraturbinate segment of the posterior nasal nerves, with 15–20 punctures on each turbinate. Second, laser PNNN was performed using a 2-W continuous wave laser with the AcuPulse CO<sub>2</sub> laser (Lumenis Ltd., Yokne'am Illit, Israel) transmitted via a nasal probe with a straight-tip 90°mirror. Each side takes 2–3 min to complete the ablation. After the procedure, the inferior turbinate head was covered with Hemopatch (Baxter International, Deerfield, US) to prevent bleeding, which could be removed within 1 week and keeps the inferior meatus patent after removal.</p><p>Of the 54 enrolled in the study, 50 completed the 6-month follow-ups. The enrolled patient's characteristics, procedure information, and baseline rhinitis data are reported in Table 1.</p><p>Both rTNSS and NOSE scores showed significant post-surgical improvement. From baseline scores of 8.7 (95% CI, 8.2–9.2) and 61.6 (95% CI, 56.8–","PeriodicalId":13716,"journal":{"name":"International Forum of Allergy & Rhinology","volume":"15 5","pages":"565-567"},"PeriodicalIF":7.2,"publicationDate":"2025-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/alr.23580","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143780057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"3-Year Outcomes of Temperature-Controlled Radiofrequency Ablation of the Posterior Nasal Nerve in Patients With Chronic Rhinitis.","authors":"J Pablo Stolovitzky, Randall A Ow, Stacey L Silvers, Bobby A Tajudeen, Chad M McDuffie, Marc Dean, Ahmad R Sedaghat, Katie Phillips, Masayoshi Takashima","doi":"10.1002/alr.23577","DOIUrl":"https://doi.org/10.1002/alr.23577","url":null,"abstract":"<p><strong>Background: </strong>Temperature-controlled radiofrequency (TCRF) ablation of the posterior nasal nerve has been shown to improve chronic rhinitis (CR) symptoms and quality of life (QoL). This study assesses the durability of TCRF's effectiveness and safety 3 years post-procedure in patients with perennial allergic CR and nonallergic CR.</p><p><strong>Methodology: </strong>This prospective, multicenter, single-blinded, randomized controlled trial included a sham control arm and long-term follow-up. Analysis combined patients from the active treatment and control crossover arms. Outcomes include reflective total nasal symptom score (rTNSS), postnasal drip (PND), and cough scores, as well as QoL measured by the Mini Rhinoconjunctivitis Quality-of-Life Questionnaire (MiniRQLQ).</p><p><strong>Results: </strong>Of 104 patients who underwent TCRF, 59 participated in the 3-year follow-up. The baseline mean rTNSS was 8.2 (95% confidence interval [95% CI, 7.9-8.6]), reduced to 3.5 (95% CI, 2.9-4.1) at 3 years, a 57.3% reduction and mean change of -4.7 (95% CI, -5.3 to -4.1; p < 0.0001). Most patients (79.7%) were responders. Cough scores decreased from a mean baseline of 1.5 (95% CI, 1.3-1.7) to 0.7 (95% CI, 0.5-0.9; mean change, -0.8; p < 0.0001). PND symptoms were also reduced from 2.5 (95% CI, 2.4 - 2.7) to 1.4 (95% CI, 1.2-1.7; mean change, -1.1; p < 0.0001). No severe adverse events were reported throughout the study, and no adverse events were reported between 24 months and 36 months of follow-up.</p><p><strong>Conclusion: </strong>TCRF ablation of the posterior nasal nerve provided sustained safety and improvement in CR symptoms, cough, postnasal drip, and patient-reported QoL at 3 years, supporting its long-term safety and efficacy in CR.</p>","PeriodicalId":13716,"journal":{"name":"International Forum of Allergy & Rhinology","volume":" ","pages":"e23577"},"PeriodicalIF":7.2,"publicationDate":"2025-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143780054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Response to the Letter to the Editor Regarding “Readability of Rhinology-Related Patient Education Materials Generated by Artificial Intelligence-Based Chatbots”","authors":"Amani Kais,&nbsp;John Nguyen,&nbsp;Hassan H Ramadan,&nbsp;Ruifeng Cui,&nbsp;Chadi A. Makary","doi":"10.1002/alr.23586","DOIUrl":"10.1002/alr.23586","url":null,"abstract":"","PeriodicalId":13716,"journal":{"name":"International Forum of Allergy & Rhinology","volume":"15 5","pages":"572"},"PeriodicalIF":7.2,"publicationDate":"2025-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143780058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Efficacy and Safety of Combined Pharmacotherapies in Moderate-to-Severe Allergic Rhinitis: A Network Meta-Analysis.","authors":"Yuan Zhang, Zengxiao Zhang, Chengshuo Wang, Luo Zhang","doi":"10.1002/alr.23578","DOIUrl":"https://doi.org/10.1002/alr.23578","url":null,"abstract":"<p><strong>Background: </strong>Combination pharmacotherapies are often selected for moderate-to-severe allergic rhinitis (AR), particularly when monotherapies do not control symptoms effectively. However, few studies have compared the efficacy and safety of different combination regimens. Therefore, we performed this study to investigate the clinical benefits of different combination strategies for moderate-to-severe AR.</p><p><strong>Methods: </strong>Electronic databases were searched (inception-May 31, 2024) for randomized controlled trials involving combination therapies for treating moderate-to-severe AR. The medication classes included intranasal corticosteroids (INCS), intranasal antihistamines (INAH), oral antihistamines (OAH), and oral leukotriene receptor antagonists (LTRA). A network meta-analysis with a random-effects model was performed following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.</p><p><strong>Results: </strong>Forty-eight eligible studies with 17,188 participants were included. In this meta-analysis, INAH and INCS, OAH and INCS, and INCS were the most effective in improving Total Nasal Symptom Score, and INAH and INCS, INAH, and INCS most effectively enhanced the total ocular symptom score. INCS and LTRA, OAH and INCS, and INAH and INCS showed the greatest benefit in improving the Rhinitis Quality of Life Questionnaire. Although INCS and INAH and INAH increased the risk of overall adverse events, specific adverse events predominantly included a bitter taste.</p><p><strong>Conclusion: </strong>Combination therapies demonstrated superior efficacy compared to monotherapies overall. The INAH and INCS combination provided the greatest advantage in symptom improvement. The combination of OAH and INCS could be a viable alternative treatment option if the bitter taste is unacceptable. Our findings provide novel insights into optimizing personalized combination therapies.</p>","PeriodicalId":13716,"journal":{"name":"International Forum of Allergy & Rhinology","volume":" ","pages":"e23578"},"PeriodicalIF":7.2,"publicationDate":"2025-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143709154","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"June 4: International Skull Base Surgery Day","authors":"David A. Gudis,&nbsp;Benjamin S. Bleier,&nbsp;Jean Anderson Eloy,&nbsp;James J. Evans,&nbsp;Juan Carlos Fernandez-Miranda,&nbsp;Paul A. Gardner,&nbsp;Mathew Geltzeiler,&nbsp;Jessica W. Grayson,&nbsp;Richard J. Harvey,&nbsp;Elisa A. Illing,&nbsp;David W. Kennedy,&nbsp;Cristine Klatt-Cromwell,&nbsp;Edward C. Kuan,&nbsp;Jivianne Lee,&nbsp;Michael J. Link,&nbsp;James K. Liu,&nbsp;Patricia Loftus,&nbsp;Nyall R. London,&nbsp;Erin L. McKean,&nbsp;Kibwei A. McKinney,&nbsp;L. Madison Michael,&nbsp;Gurston G. Nyquist,&nbsp;Zara M. Patel,&nbsp;Mindy Rabinowitz,&nbsp;Sanjeet V. Rangarajan,&nbsp;M. Eng,&nbsp;Kenneth D. Rodriguez,&nbsp;Nicholas R. Rowan,&nbsp;Rodney J. Schlosser,&nbsp;Kafui Searyoh,&nbsp;Raymond F. Sekula Jr.,&nbsp;Timothy L. Smith,&nbsp;Carl Snyderman,&nbsp;Satyan B. Sreenath,&nbsp;Dennis M. Tang,&nbsp;Brian D. Thorp,&nbsp;Eric W. Wang,&nbsp;Marilene B. Wang,&nbsp;Bradford A. Woodworth,&nbsp;Garret Choby","doi":"10.1002/alr.23545","DOIUrl":"10.1002/alr.23545","url":null,"abstract":"","PeriodicalId":13716,"journal":{"name":"International Forum of Allergy & Rhinology","volume":"15 5","pages":"481-482"},"PeriodicalIF":7.2,"publicationDate":"2025-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143709186","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"MiR-221-3p Attenuates IL-33-Induced Mast Cell Cytokine Expression by Targeting KIT.","authors":"Ruowu Liu, Jiao Zhou, Jing Zhou, Feng Liu, Yafeng Liu, Juan Meng, Luo Ba, Hengyi Xiao, Shixi Liu, Nan Zhang, Claus Bachert, Jintao Du","doi":"10.1002/alr.23558","DOIUrl":"https://doi.org/10.1002/alr.23558","url":null,"abstract":"<p><strong>Background: </strong>Mast cells (MCs) are involved in type 2 inflammation in chronic rhinosinusitis with nasal polyps (CRSwNP), which depends on interleukin (IL)-33 stimulation. MiR-221 is reported to be an important regulator of MCs, and miR-221-3p can be expressed in CRSwNP. However, the role of miR-221-3p in CRSwNP is unclear.</p><p><strong>Methods: </strong>Ethmoid tissues from control subjects (n = 12) and polyps from patients with CRSwNP (n = 40) were collected. The expression of miR-221-3p and cytokines was detected by real-time quantitative polymerase chain reaction (qPCR). The activation of P65 and ERK was determined by western blotting. The localization of miR-221-3p was detected via in situ hybridization combined with immunofluorescence (IF), and its target was identified via a luciferase reporter system. Human MCs were incubated with IL-33 or stem cell factor. MicroRNA mimics/inhibitor and lentiviral plasmids were used to determine the role of miR-221-3p in MCs.</p><p><strong>Results: </strong>We observed increased expression of miR-221-3p in CRSwNP, and localized its expression in MCs. The expression of miR-221-3p was negatively correlated with that of IL-4, IL-5, and IL-13 in CRSwNP. MiR-221-3p can be induced by IL-33 in MCs and plays a negative regulatory role in cytokine expression and signaling pathways in IL-33-induced MC activation. As the direct target of miR-221-3p, the receptor KIT was negatively correlated with miR-221-3p and decreased in CRSwNP. In MCs, KIT is essential for an effective response to IL-33 stimulation. We here demonstrated that miR-221-3p regulates cytokine expression by targeting KIT in IL-33-activated MCs.</p><p><strong>Conclusions: </strong>MiR-221-3p inhibits MC-dependent type 2 inflammatory conditions, rendering it a negative regulator of CRSwNP.</p>","PeriodicalId":13716,"journal":{"name":"International Forum of Allergy & Rhinology","volume":" ","pages":"e23558"},"PeriodicalIF":7.2,"publicationDate":"2025-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143700394","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Correspondence Regarding “Readability of Rhinology-Related Patient Education Materials Generated by Artificial Intelligence-Based Chatbots”","authors":"Simon Høj,&nbsp;Howraman Meteran","doi":"10.1002/alr.23585","DOIUrl":"10.1002/alr.23585","url":null,"abstract":"","PeriodicalId":13716,"journal":{"name":"International Forum of Allergy & Rhinology","volume":"15 5","pages":"568-569"},"PeriodicalIF":7.2,"publicationDate":"2025-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143700393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}